Home
Latest
E-paper
Companies
Industry
Economy
Finance
Markets
Budget 2025
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Video Gallery
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Cadila board approves transfer of animal healthcare arm to Zydus Health
The transfer of animal healthcare business is through execution of a definitive agreement, Cadila Healthcare said in a filing to BSE
Sugar Free's bitter battle with online misinformation, competitive brands
To become part of the consumer's monthly shopping cart, Sugar Free has launched new formats and variants and waged war against online venom
Zydus receives tentative approval from USFDA for Tofacitinib tablets
It helps to decrease pain, tenderness and swelling in the joints
Zydus gets regulatory nod to sell diabetes drug in Mexico
Lipaglyn, a prescription drug, was first launched in India during September 2013, Zydus said
Zydus gets USFDA nod to market Tranexamic acid injection
The injection is used to prevent bleeding in patients with hemophilia undergoing tooth extraction
Zydus' Nesher Pharma gets US FDA nod for antifungal drug
The drug will be produced at Nesher Pharmaceuticals manufacturing facility in USA
Zydus Cadila acquires 6 brands from American pharma MSD
These fall in men's health, women's health, cardiovascular and wound management therapy segments
Zydus can launch ulcer drug in US, patent litigation settled
The patent litigation relating to Allergan's Delzicol has been settled, Zydus Cadila said in a statement
Zydus to launch immunosupressant drug Grafalon
The market for transplant-immuno therapies is estimated at Rs 483 crore
Zydus acquires derma brand Melgain from Issar Pharma
The brand will be marketed by Liva Healthcare, the group's division catering to dermatological segment
Zydus gets FDA nod for anti-viral Acyclovir capsules
This would be the third drug approval for the US markets for the Group this year apart from a tentative approval